The combination products market continues to grow, providing precision technologies in drug delivery for therapeutic care. Market opportunities abound for companies to converge their expertise, resources, and technologies for advancement of combination products. This panel discussion will examine business and intellectual property strategies, licensing and collaborative opportunities, and technology innovations arising in the near future.

Chair: Ron Sills, Nerac

Panelists:
Thomas Gunderson, Senior Research Analyst, Piper Jaffray
Rob Cottone, Vice President of IP and Technology, OrbusNeich Medical
Richard Taney, CEO, Delcath Systems, Inc.
Arthur Erdman, PhD, Center Director, University of Minnesota

The cardiovascular market is easily the largest subsector in the device industry. Technological advances in the cardio sector are changing the landscape of this sector, and investment remains strong in many areas, including stents, transcatheter valves, and cardiac rhythm disease management. This panel discussion will examine the investment opportunities, as well as the underlying technologies and the future of these devices in improving healthcare efficiency and patient care.

Chair: Sherrie Conroy, Editor, MD&DI Magazine

Panelists:
Dr. Mark Landy, President, Chief Executive Officer and Director, MIV Therapeutics Inc.
Hans Hinrichs, Vice President, GE Capital
Dr. Andrew Reed, Vice President of Science and Technology, AdvanSource Biomaterials
Additional panelists to be announced